177lu-psma-617
novartis
['prostate', 'novartis']
at #asco22, researchers shared efforts to better define which prostate cancer patients benefit most from novartis' and how to optimize selection w/ psma pet imaging. but the discussions came against the backdrop of real-world access issues 
Health & science journalist ???Biopharma reporter @PrecOncNews @GenomeWeb?Past: @ASCO, @ColumbiaJourn?I cover cancer treatment??, genomics??, + sometimes ??s